Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Umbilical Cord Blood in Children with Type 1 Diabetes
NCT00305344Phase 2Completed
- Sponsor
- University of Florida
- Start
- Apr 2005
- Primary completion
- May 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous umbilical cord blood in type 1 diabetes mellitus (T1D), sponsored by University of Florida. Primary endpoint: Children With T1D Underwent a Single Autologous UCB Transfusion at 2 years. Started Apr 2005; status: completed.
02
Drugs
autologous umbilical cord blood
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00305344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305344.